
Paul M. Rivard
Examiner (ID: 3272)
| Most Active Art Unit | 1304 |
| Art Unit(s) | 2899, 1304, 1734 |
| Total Applications | 355 |
| Issued Applications | 271 |
| Pending Applications | 27 |
| Abandoned Applications | 57 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18002789
[patent_doc_number] => 20220361555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => INHIBITION OF UNDESIRED SENSORY EFFECTS BY THE COMPOUND CAMPHOR
[patent_app_type] => utility
[patent_app_number] => 17/751959
[patent_app_country] => US
[patent_app_date] => 2022-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3331
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17751959
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/751959 | INHIBITION OF UNDESIRED SENSORY EFFECTS BY THE COMPOUND CAMPHOR | May 23, 2022 | Pending |
Array
(
[id] => 19316662
[patent_doc_number] => 20240238202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/561555
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561555 | LIPID NANOPARTICLES | May 18, 2022 | Pending |
Array
(
[id] => 19316662
[patent_doc_number] => 20240238202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => LIPID NANOPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/561555
[patent_app_country] => US
[patent_app_date] => 2022-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561555
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561555 | LIPID NANOPARTICLES | May 18, 2022 | Pending |
Array
(
[id] => 19316878
[patent_doc_number] => 20240238418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => CAR T CELL THERAPY METHOD
[patent_app_type] => utility
[patent_app_number] => 18/289705
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22687
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18289705
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/289705 | CAR T CELL THERAPY METHOD | May 5, 2022 | Pending |
Array
(
[id] => 17805654
[patent_doc_number] => 20220257489
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => Compositions and Methods for the Removal of Tattoos
[patent_app_type] => utility
[patent_app_number] => 17/735969
[patent_app_country] => US
[patent_app_date] => 2022-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14465
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17735969
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/735969 | Compositions and methods for the removal of tattoos | May 2, 2022 | Issued |
Array
(
[id] => 19265662
[patent_doc_number] => 20240209361
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/288457
[patent_app_country] => US
[patent_app_date] => 2022-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18288457
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/288457 | TREATING CANCER | Apr 26, 2022 | Pending |
Array
(
[id] => 17944272
[patent_doc_number] => 20220331289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery
[patent_app_type] => utility
[patent_app_number] => 17/724554
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6824
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17724554
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/724554 | Pharmaceutical Composition Comprising an Artemisinin Derivative for Nasal or Pulmonary Delivery | Apr 19, 2022 | Abandoned |
Array
(
[id] => 17774167
[patent_doc_number] => 20220240516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => DISPERSION LIQUID, METHOD FOR PRODUCING THE SAME, AND COPPER COMPOUND PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/722169
[patent_app_country] => US
[patent_app_date] => 2022-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17722169
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/722169 | DISPERSION LIQUID, METHOD FOR PRODUCING THE SAME, AND COPPER COMPOUND PARTICLES | Apr 14, 2022 | Abandoned |
Array
(
[id] => 17805773
[patent_doc_number] => 20220257608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => Dry Powder Treprostinil for the Treatment of Pulmonary Hypertension
[patent_app_type] => utility
[patent_app_number] => 17/719439
[patent_app_country] => US
[patent_app_date] => 2022-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17719439
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/719439 | Dry powder treprostinil for the treatment of pulmonary hypertension | Apr 12, 2022 | Issued |
Array
(
[id] => 17748163
[patent_doc_number] => 20220226366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => SUBSTITUTED PHENYL BORONIC ACID CONTAINING POLYMERS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/715619
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13392
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715619
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715619 | Substituted phenyl boronic acid containing polymers and methods of use | Apr 6, 2022 | Issued |
Array
(
[id] => 17974346
[patent_doc_number] => 11491183
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-08
[patent_title] => Substituted phenyl boronic acid containing polymers and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/715625
[patent_app_country] => US
[patent_app_date] => 2022-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13420
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17715625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/715625 | Substituted phenyl boronic acid containing polymers and methods of use | Apr 6, 2022 | Issued |
Array
(
[id] => 18271064
[patent_doc_number] => 20230092306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => SUBSTANCE DELIVERY CARRIER AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/711528
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711528 | SUBSTANCE DELIVERY CARRIER AND COMPOSITION | Mar 31, 2022 | Pending |
Array
(
[id] => 18271064
[patent_doc_number] => 20230092306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => SUBSTANCE DELIVERY CARRIER AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/711528
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711528
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711528 | SUBSTANCE DELIVERY CARRIER AND COMPOSITION | Mar 31, 2022 | Pending |
Array
(
[id] => 19528072
[patent_doc_number] => 20240351974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => NOVEL CATIONIC LIPID COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/681557
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18681557
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/681557 | NOVEL CATIONIC LIPID COMPOUNDS | Mar 30, 2022 | Pending |
Array
(
[id] => 17718890
[patent_doc_number] => 20220211609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => METHOD FOR CONTROLLING DENTAL CARIES AND TREATING TEETH SENSITIVITY
[patent_app_type] => utility
[patent_app_number] => 17/705904
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11364
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17705904
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/705904 | Method for controlling dental caries and treating teeth sensitivity | Mar 27, 2022 | Issued |
Array
(
[id] => 19279816
[patent_doc_number] => 20240216288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/282640
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282640 | LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS AND USES THEREOF | Mar 23, 2022 | Pending |
Array
(
[id] => 19830784
[patent_doc_number] => 20250082570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => COMBINATION THERAPY FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/372339
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -79
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18372339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/372339 | COMBINATION THERAPY FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE | Mar 23, 2022 | Pending |
Array
(
[id] => 19830784
[patent_doc_number] => 20250082570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-13
[patent_title] => COMBINATION THERAPY FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/372339
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -79
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18372339
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/372339 | COMBINATION THERAPY FOR TREATING NON-TUBERCULOUS MYCOBACTERIAL LUNG DISEASE | Mar 23, 2022 | Pending |
Array
(
[id] => 19279816
[patent_doc_number] => 20240216288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/282640
[patent_app_country] => US
[patent_app_date] => 2022-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87817
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -39
[patent_words_short_claim] => 305
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282640
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282640 | LIPID NANOPARTICLES CONTAINING POLYNUCLEOTIDES ENCODING PROPIONYL-COA CARBOXYLASE ALPHA AND BETA SUBUNITS AND USES THEREOF | Mar 23, 2022 | Pending |
Array
(
[id] => 19170770
[patent_doc_number] => 20240156744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-16
[patent_title] => METHOD OF APPLYING ELECTRICAL IMPULSES FOR THE PURPOSE OF LOADING VARIOUS MOLECULES INTO PLANT-DERIVED NANOVESICLES
[patent_app_type] => utility
[patent_app_number] => 18/282465
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4498
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282465
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/282465 | METHOD OF APPLYING ELECTRICAL IMPULSES FOR THE PURPOSE OF LOADING VARIOUS MOLECULES INTO PLANT-DERIVED NANOVESICLES | Mar 22, 2022 | Pending |